- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02663336
Prevalence of Masked Hypertension in Nephrological Patients
October 27, 2021 updated by: Waid City Hospital, Zurich
The purpose of this study is to determine the percentage of patients with masked hypertension in a population with chronic kidney disease.
The investigators goal is to register prospectively ambulatory blood pressure measurement results of patients of a nephrological outpatient clinic with normal office blood pressure to finally find the percentage of masked hypertension in this population.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Anticipated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Andreas Schleich
- Phone Number: -41 44 36621 11
- Email: Andreas.schleich@waid.zuerich.ch
Study Locations
-
-
-
Zurich, Switzerland, 8037
- Recruiting
- Stadtspital Waid Zurich
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 90 years (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Sampling Method
Probability Sample
Study Population
Patients with chronic kidney disease of the nephrological outpatient clinic of Waidspital with normal office blood pressure in the context of diagnosed arterial hypertension with or without antihypertensive medication
Description
Inclusion Criteria:
- Age: 20-90 years
- Known arterial hypertension and antihypertensive medical treatment
- Office blood pressure < 140 mmHg systolic and <90 mmHg diastolic
Exclusion Criteria:
- Age <20 or >90 years
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
CKD patients
Patients with chronic kidney disease, with diagnosed arterial hypertension and normal blood pressure during office blood pressure measurement.
Comparison of ambulatory blood pressure (ABPM) with office blood pressure measurements (OBPM).
|
No interventions
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Number of participants with uncontrolled masked hypertension assessed by comparison of ambulatory blood pressure with office blood pressure
Time Frame: 2 years
|
2 years
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Andreas Schleich, Stadtspital Waid Zurich Switzerland
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
December 1, 2015
Primary Completion (ANTICIPATED)
January 1, 2023
Study Completion (ANTICIPATED)
November 1, 2023
Study Registration Dates
First Submitted
January 18, 2016
First Submitted That Met QC Criteria
January 21, 2016
First Posted (ESTIMATE)
January 26, 2016
Study Record Updates
Last Update Posted (ACTUAL)
October 28, 2021
Last Update Submitted That Met QC Criteria
October 27, 2021
Last Verified
October 1, 2021
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- WaidBP16
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Masked Hypertension
-
National Taiwan University Hospital Hsin-Chu BranchRecruitingHypertension,Essential | Hypertension, MaskedTaiwan
-
University Hospital of CologneUnknownNAFLD; Hypertension, White-coat Hypertension, Masked HypertensionGermany
-
Jing LiuHUAWEINot yet recruitingMasked HypertensionChina
-
Shanghai Institute of HypertensionUnknownMasked HypertensionChina
-
University of Sao Paulo General HospitalConselho Nacional de Desenvolvimento Científico e TecnológicoActive, not recruitingPrehypertension | Masked HypertensionBrazil
-
Istituto Auxologico ItalianoEuropean Society of HypertensionRecruitingMasked HypertensionItaly, Venezuela
-
University of Alabama at BirminghamWithdrawn
-
Yan LiCompleted
-
University of MinnesotaCompletedHypertension | Masked Hypertension | Chronic Renal InsufficiencyUnited States
-
Third Affiliated Hospital of Third Military Medical...UnknownObesity | Overweight | Type 2 Diabetes | Masked Hypertension
Clinical Trials on Comparison ABPM with OBPM
-
Hippocration General HospitalNational and Kapodistrian University of Athens; Biomedical Research Foundation...RecruitingHypertension | Proteomics | Renal DenervationGreece
-
Consorci d'Atenció Primària de Salut de l'EixampleInstituto de Salud Carlos IIICompleted
-
Johns Hopkins UniversityMedivators CantelCompletedInfectionUnited States
-
Denver Health and Hospital AuthorityCompletedShock, Septic | Community Acquired Pneumonia
-
Accure TherapeuticsSimbec ResearchCompletedOptic Neuritis | Optic; Neuritis, With DemyelinationUnited Kingdom
-
Centre Hospitalier Universitaire de Saint EtienneCompletedAutoimmune DiseasesFrance
-
Therasid BioscienceCompletedHealthy VolunteersKorea, Republic of
-
Barts & The London NHS TrustCompleted
-
Hvidovre University HospitalOdense University Hospital; Aarhus University Hospital; Rigshospitalet, Denmark; Aalborg University Hospital and other collaboratorsCompletedSARS-CoV2 Infection | COVID-19 TestingDenmark